Area of research
Molecular Biology · Oncology
Research interest
Research interests include Biology, Ribosome, Ribosomal RNA, Cancer research, Translation (biology), and Ribosome biogenesis.
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology
SnoBIRD: a tool to identify C/D box snoRNAs and refine their annotation across all eukaryotes
SnoBIRD: A tool to identify C/D box snoRNAs and refine their annotation across all eukaryotes
<i>Isocitrate dehydrogenase</i> wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2’O-methylation of ribosomal RNA
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor−Positive Recurrent or Metastatic Endometrial Cancer
snoDB 2.0: an enhanced interactive database, specializing in human snoRNAs
Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer
A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate
2′O-Ribose Methylation of Ribosomal RNAs: Natural Diversity in Living Organisms, Biological Processes, and Diseases
Ribosomal RNA 2′O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer
Iron and hepcidin mediate human colorectal cancer cell growth
Ribosome Biogenesis Alterations in Colorectal Cancer
snoRNAs Offer Novel Insight and Promising Perspectives for Lung Cancer Understanding and Management
Analysis of the rRNA methylation complex components in pediatric B-cell precursor acute lymphoblastic leukemia: A pilot study
Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance
Emerging Role of Eukaryote Ribosomes in Translational Control
The Nonstructural NS1 Protein of Influenza Viruses Modulates <i>TP53</i> Splicing through Host Factor CPSF4
Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics
2′-O-Methylation of Ribosomal RNA: Towards an Epitranscriptomic Control of Translation?
40 Years of Research Put p53 in Translation
Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes
Evidence for rRNA 2′-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes
Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients
Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism
p53, a translational regulator: contribution to its tumour-suppressor activity
Ribosome heterogeneity in tumorigenesis: the rRNA point of view
p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer
Host microRNA molecular signatures associated with human H1N1 and H3N2 influenza A viruses reveal an unanticipated antiviral activity for miR-146a
Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures